Primary Care Physicians’ Knowledge and Practice Patterns in the Treatment of Chronic Kidney Disease: An Upstate New York Practice-based Research Network (UNYNET) Study

References

1. ↵
   Hostetter TH, Lising M. National kidney disease education program. J Am Soc Nephrol 2003; 14: S114–6.

   OpenUrlAbstract/FREE Full Text
2. ↵
   Nickolas TL, Frisch GD, Opotowsky AR, Arons R, Radhakrishnan J. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis 2004; 44: 185–97.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes [Review]. Am J Kidney Dis 2003; 41: 903–24.

   OpenUrlCrossRefPubMedWeb of Science
4. Kausz ATMM, Levey ASM. The care of patients with chronic kidney disease: what must we do and who should do it? [Editorial]. J Gen Intern Med 2002; 17: 659–63.

   OpenUrlCrossRef
5. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141: 95–101.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   Levey AS, Coresh J, Balk E, et al. National Kidney Foundation Practice Guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–47.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Parmar MS. Chronic renal disease. BMJ 2002; 325: 85–90.

   OpenUrlFREE Full Text
8. ↵
   Wetterhall SF, Olson DR, DeStefano F, et al. Trends in diabetes and diabetic complications, 1980–1987. Diabetes Care. 1992; 15: 960–7.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Coresh J, Astor B, Sarnak MJ. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2004; 13: 73–81.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050–65.

    OpenUrlFREE Full Text
11. ↵
    Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–305.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285–95.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Johnson DW. Evidence-based guide to slowing the progression of early renal insufficiency. Intern Med J 2004; 34: 50–7.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Lameire N, Stevens P, Raptis S, Thomas S, Schernthaner G. Individualized risk management in diabetics: how to implement best practice guidelines–design and concept of the IRIDIEM studies. Kidney Blood Press Res 2004; 27: 127–33.

    OpenUrlCrossRefPubMed
15. ↵
    Snively CS, Gutierrez C. Chronic kidney disease: prevention and treatment of common complications. Am Fam Physician 2004; 70: 1921–8.

    OpenUrlPubMedWeb of Science
16. ↵
    Boos C. Cardiovascular protection with ace inhibitors—more HOPE for EUROPA? Med Sci Monit 2004; 10: SR23–8.

    OpenUrlPubMedWeb of Science
17. ↵
    Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66: 753–60.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? J Nephrol 2004; 17: 749–61.

    OpenUrlPubMedWeb of Science
19. ↵
    Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults: part I. definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician 2004; 70: 869–76.

    OpenUrlPubMedWeb of Science
20. ↵
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461–70.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    Kuzel AJ. Sampling in qualitative research. In: Crabtree BF, Miller WL, editors. Doing qualitative research. Thousand Oaks (CA): Sage Publications, Inc.; 1999. p. 33–45.
22. ↵
    Miller WL, Crabtree BF. Depth interviewing. In: Crabtree BF, Miller WL, editors. Doing qualitative research. Thousand Oaks (CA): Sage Publications, Inc.; 1999. p. 89–107.
23. ↵
    Borkan J. Immersion/crystallization. In: Crabtree B, Miller W, editors. Doing qualitative research. Thousand Oaks (CA): Sage Publications, Inc.; 1999. p. 20–4.
24. ↵
    Miller WL, Crabtree BF. Primary care research: a multimethod typology and qualitative road map. In: Miller WL, editor. Doing qualitative research. Newbury Park (CA): Sage Publications, Inc.; 1992. p. 3–28.
25. ↵
    Kuzel AJ, Like RC. Standards of trustworthiness for qualitative studies in primary care. In: Dunn EV, editor. Primary care research: traditional and innovative approaches. Vol. 1. Newbury Park (CA): Sage Publications, Inc.; 1991. p. 138–158.
26. ↵
    Jaen CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994; 38: 166–71.

    OpenUrlPubMedWeb of Science
27. ↵
    Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–52.

    OpenUrlAbstract/FREE Full Text
28. ↵
    Lauer MS, Fontanarosa PB. Updated guidelines for cholesterol management. JAMA 2001; 285: 2508–9.

    OpenUrlCrossRefPubMedWeb of Science
29. ↵
    K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43: S1–290.

    OpenUrlPubMed
30. ↵
    Al Aly Z, Gonzalez EA, Martin KJ, Gellens ME. Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle. Am J Nephrol 2004; 24: 422–6.

    OpenUrlCrossRefPubMedWeb of Science